Mark Swanson

Corporate Officer/Principal presso Gel Med Sciences, Inc.

Health Technology

Consumer Services

Commercial Services

Posizioni attive di Mark Swanson

Società	Posizione	Inizio	Fine
Gel Med Sciences, Inc. Gel Med Sciences, Inc. Pharmaceuticals: MajorHealth Technology Gel Med Sciences, Inc. engages in the development of animal and human healthcare products. It offers ovugel that utilizes the company's gel drug delivery system to improve the timing of artificial inseminations in pig herds. The company was founded by Joseph S Duffey in 1999 and is headquartered in Wayne, PA.	Corporate Officer/Principal	-	-
	Direttore Tecnico/Scientifico/R&S	04/01/2010	-

Società	Posizione	Inizio	Fine
DNX Transgenic Sciences DNX Transgenic Sciences Miscellaneous Commercial ServicesCommercial Services Part of Revvity, Inc., DNX Transgenic Sciences is an American company that provides contract research services and transgenic animal technologies to the biomedical research community. The company is based in NJ. DNX Transgenic Sciences was acquired by Xenogen Corp., a subsidiary of Revvity, Inc. from Nordion (Canada), Inc. on November 13, 2000 for $35 million.	Corporate Officer/Principal	-	-
Sandoz Pharmaceuticals Corp.	Direttore Tecnico/Scientifico/R&S	-	-

University of Connecticut

Doctorate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Chief Tech/Sci/R&D Officer	2
Corporate Officer/Principal	2
Doctorate Degree	1

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	3
Gel Med Sciences, Inc. Gel Med Sciences, Inc. Pharmaceuticals: MajorHealth Technology Gel Med Sciences, Inc. engages in the development of animal and human healthcare products. It offers ovugel that utilizes the company's gel drug delivery system to improve the timing of artificial inseminations in pig herds. The company was founded by Joseph S Duffey in 1999 and is headquartered in Wayne, PA.	Health Technology
Sandoz Pharmaceuticals Corp.
DNX Transgenic Sciences DNX Transgenic Sciences Miscellaneous Commercial ServicesCommercial Services Part of Revvity, Inc., DNX Transgenic Sciences is an American company that provides contract research services and transgenic animal technologies to the biomedical research community. The company is based in NJ. DNX Transgenic Sciences was acquired by Xenogen Corp., a subsidiary of Revvity, Inc. from Nordion (Canada), Inc. on November 13, 2000 for $35 million.	Commercial Services